microbiome therapy

CAMBRIDGE, Mass., April 2, 2026 Vedanta Biosciences announced that its pivotal Phase 3 RESTORATiVE303 clinical trial of VE303 will...

LYON, France, April 1, 2026 MaaT Pharma has announced the publication of CHRONOS study data in the peer-reviewed Bone...